Novartis Ag (NVSEF) EBT Margin Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) EBT Margin Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1,208.00
Jun 30, 2024 831.00
Dec 31, 2023 -88,804.00
Jun 30, 2023 -3,908.00
Mar 31, 2023 154.32 Mn
Dec 31, 2022 184,846.00
Sep 30, 2022 -59,838.00
Jun 30, 2022 -293.00
Mar 31, 2022 -46,712.00
Dec 31, 2021 4,156.00
Sep 30, 2021 -39,517.00
Jun 30, 2021 -103,646.00
Mar 31, 2021 -17.81 Bn
Dec 31, 2020 202,851.00
Sep 30, 2020 39,118.00
Jun 30, 2020 -21,811.00
Mar 31, 2020 -14,550.00
Jun 30, 2019 11,397.00
Mar 31, 2019 -60,091.00
Jun 30, 2018 7,706.00